These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 23876364)

  • 1. Impact of adjuvant external beam radiotherapy on survival in surgically resected gallbladder adenocarcinoma: a propensity score-matched Surveillance, Epidemiology, and End Results analysis.
    Hyder O; Dodson RM; Sachs T; Weiss M; Mayo SC; Choti MA; Wolfgang CL; Herman JM; Pawlik TM
    Surgery; 2014 Jan; 155(1):85-93. PubMed ID: 23876364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimating survival benefit of adjuvant therapy based on a Bayesian network prediction model in curatively resected advanced gallbladder adenocarcinoma.
    Geng ZM; Cai ZQ; Zhang Z; Tang ZH; Xue F; Chen C; Zhang D; Li Q; Zhang R; Li WZ; Wang L; Si SB
    World J Gastroenterol; 2019 Oct; 25(37):5655-5666. PubMed ID: 31602165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postsurgical radiotherapy in stage IIIB gallbladder cancer patients with one to three lymph nodes metastases: A propensity score matching analysis.
    Cai YL; Lin YX; Xiong XZ; Ye H; Li FY; Cheng NS
    Am J Surg; 2021 Mar; 221(3):642-648. PubMed ID: 32859350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvant external beam radiation therapy with concurrent chemotherapy in the management of gallbladder carcinoma.
    Kresl JJ; Schild SE; Henning GT; Gunderson LL; Donohue J; Pitot H; Haddock MG; Nagorney D
    Int J Radiat Oncol Biol Phys; 2002 Jan; 52(1):167-75. PubMed ID: 11777635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant radiation therapy is associated with improved survival for gallbladder carcinoma with regional metastatic disease.
    Mojica P; Smith D; Ellenhorn J
    J Surg Oncol; 2007 Jul; 96(1):8-13. PubMed ID: 17516546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic Impact of Neoadjuvant Chemotherapy in Localized or Locoregionally Advanced Gallbladder Cancer: A Population-Based and Propensity Score Matched SEER Analysis.
    Xiong YC; Yang ZY; Gong A; Wu ZY; Liu SL; Zhu YD; Song XL; Chu BF; Wu XS; Gong W
    Cancer Control; 2024; 31():10732748241271682. PubMed ID: 39105433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of external-beam radiation therapy on outcomes among patients with resected gastric cancer: a multi-institutional analysis.
    Ejaz A; Spolverato G; Kim Y; Squires MH; Poultsides G; Fields R; Bloomston M; Weber SM; Votanopoulos K; Worhunsky DJ; Swords D; Jin LX; Schmidt C; Acher AW; Saunders N; Cho CS; Herman JM; Maithel SK; Pawlik TM
    Ann Surg Oncol; 2014 Oct; 21(11):3412-21. PubMed ID: 24845728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of Adjuvant Radiation Therapy for Resected Gallbladder Carcinoma: A Multi-institutional Experience.
    Wang J; Narang AK; Sugar EA; Luber B; Rosati LM; Hsu CC; Fuller CD; Pawlik TM; Miller RC; Czito BG; Tuli R; Crane CH; Ben-Josef E; Thomas CR; Herman JM
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3(Suppl 3):S1100-6. PubMed ID: 26224402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A national propensity-adjusted analysis of adjuvant radiotherapy in the treatment of resected pancreatic adenocarcinoma.
    McDade TP; Hill JS; Simons JP; Piperdi B; Ng SC; Zhou Z; Kadish SP; Fitzgerald TJ; Tseng JF
    Cancer; 2010 Jul; 116(13):3257-66. PubMed ID: 20564625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defining the role of adjuvant external beam radiotherapy on resected adenocarcinoma of the ampulla of vater.
    Miura JT; Jayakrishnan TT; Amini A; Johnston FM; Tsai S; Erickson B; Quebbeman EJ; Christians KK; Evans DB; Gamblin TC; Turaga KK
    J Gastrointest Surg; 2014 Nov; 18(11):2003-8. PubMed ID: 25159502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Propensity Score Analysis of Chemotherapy Use in Patients With Resectable Gallbladder Cancer.
    Ozer M; Goksu SY; Sanford NN; Porembka M; Khurshid H; Ahn C; Maxwell MC; Beg MS; Kazmi SM
    JAMA Netw Open; 2022 Feb; 5(2):e2146912. PubMed ID: 35171262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors influencing recurrence, patterns of recurrence, and the efficacy of adjuvant therapy after radical resection for gallbladder carcinoma.
    Kim WS; Choi DW; You DD; Ho CY; Heo JS; Choi SH
    J Gastrointest Surg; 2010 Apr; 14(4):679-87. PubMed ID: 20094817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of lymph node ratio in selecting patients with resected gastric cancer for adjuvant therapy.
    Kim Y; Squires MH; Poultsides GA; Fields RC; Weber SM; Votanopoulos KI; Kooby DA; Worhunsky DJ; Jin LX; Hawkins WG; Acher AW; Cho CS; Saunders N; Levine EA; Schmidt CR; Maithel SK; Pawlik TM
    Surgery; 2017 Aug; 162(2):285-294. PubMed ID: 28578142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of radiotherapy for pancreatic malignancies: a population-based analysis of the SEER database.
    Luo Y
    Clin Transl Oncol; 2022 Jan; 24(1):76-83. PubMed ID: 34219204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvant therapy for elderly patients with resected gastric adenocarcinoma: population-based practices and treatment effectiveness.
    Hoffman KE; Neville BA; Mamon HJ; Kachnic LA; Katz MS; Earle CC; Punglia RS
    Cancer; 2012 Jan; 118(1):248-57. PubMed ID: 21692071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of postoperative radiotherapy on survival in duodenal adenocarcinoma: a propensity score-adjusted analysis of Surveillance, Epidemiology, and End Results database.
    Lim YJ; Kim K
    Int J Clin Oncol; 2018 Jun; 23(3):473-481. PubMed ID: 29260430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A 21-year analysis of stage I gallbladder carcinoma: is cholecystectomy alone adequate?
    Hari DM; Howard JH; Leung AM; Chui CG; Sim MS; Bilchik AJ
    HPB (Oxford); 2013 Jan; 15(1):40-8. PubMed ID: 23216778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction model for estimating the survival benefit of adjuvant radiotherapy for gallbladder cancer.
    Wang SJ; Fuller CD; Kim JS; Sittig DF; Thomas CR; Ravdin PM
    J Clin Oncol; 2008 May; 26(13):2112-7. PubMed ID: 18378567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of Adjuvant Radiotherapy in Left-Sided Pancreatic Cancer-Population-Based Analysis with Propensity Score Matching.
    Lim YJ; Kim K; Chie EK; Kim B; Ha SW
    J Gastrointest Surg; 2015 Dec; 19(12):2183-91. PubMed ID: 26376994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. National trends in the management and survival of surgically managed gallbladder adenocarcinoma over 15 years: a population-based analysis.
    Mayo SC; Shore AD; Nathan H; Edil B; Wolfgang CL; Hirose K; Herman J; Schulick RD; Choti MA; Pawlik TM
    J Gastrointest Surg; 2010 Oct; 14(10):1578-91. PubMed ID: 20824371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.